Literature DB >> 15384259

[Spanish adaptation of the European Guidelines on Cardiovascular Disease Prevention].

Carlos Brotons1, Miguel Angel Royo-Bordonada, Luís Alvarez-Sala, Pedro Armario, Rosario Artigao, Pedro Conthe, Fernando de Alvaro, Ana de Santiago, Antonio Gil, José Maria Lobos, Antonio Maiques, Jaume Marrugat, Dídac Mauricio, Fernando Rodríguez-Artalejo, Susana Sans, Carmen Suárez.   

Abstract

We are pleased to present the European Guidelines on Cardiovascular Disease Prevention, translated and adapted by the Interdisciplinary Spanish Committee for Cardiovascular Disease Prevention. This guide is focused on the prevention of cardiovascular disease as a whole, recommending the SCORE model for risk assessment and placing priority on the care of patients and high-risk individuals. The objective is to prevent premature death due to CVD by means of dealing with its related risk factors in clinical practice. Hence, a maintained professional intervention is required in order to obtain an increase of physical activity and of healthy diets in patients high-risk individuals, and smoking cessation in smokers. The decision to start blood pressure treatment will depend upon the BP values, cardiovascular risk and possible damage to target organs. The treatment goal is to achieve BP < 140/90 mmHg, but among patients with diabetes, chronic kidney disease, a past history of ictus, coronary heart disease or heart failure, lower levels must be pursued. Serum cholesterol must be below 200 mg/dl and LDL cholesterol below 130 mg/dl, although among patients with CVD or diabetes, levels respectively below 175 mg/dl and 100 mg/dl must be pursued. Advice of a professional dietitian is always required in order to keep blood sugar levels controlled. Proper insulin therapy is required in Type I diabetes. Patients with Type II diabetes and those with metabolic syndrome must lose weight and increase their physical activity.,dngus beiln aiministered wherever applicable. Lastly, an appendix is included providing diet recommendations adapted to our environment and criteria related to referral or seeing a specialist for hypertensive or dyslipemic patients.

Entities:  

Mesh:

Year:  2004        PMID: 15384259     DOI: 10.1590/s1135-57272004000400002

Source DB:  PubMed          Journal:  Rev Esp Salud Publica        ISSN: 1135-5727


  9 in total

1.  Performance of the Framingham and SCORE cardiovascular risk prediction functions in a non-diabetic population of a Spanish health care centre: a validation study.

Authors:  Lourdes Cañón Barroso; Eloísa Cruces Muro; Natalio Díaz Herrera; Gerardo Fernández Ochoa; Juan Ignacio Calvo Hueros; Francisco Buitrago
Journal:  Scand J Prim Health Care       Date:  2010-09-27       Impact factor: 2.581

2.  Original and REGICOR Framingham functions in a nondiabetic population of a Spanish health care center: a validation study.

Authors:  Francisco Buitrago; Juan Ignacio Calvo-Hueros; Lourdes Cañón-Barroso; Gerónimo Pozuelos-Estrada; Luis Molina-Martínez; Manuel Espigares-Arroyo; Juan Antonio Galán-González; Francisco J Lillo-Bravo
Journal:  Ann Fam Med       Date:  2011 Sep-Oct       Impact factor: 5.166

3.  [European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. CEIPC 2008 Spanish Adaptation].

Authors:  José M A Lobos Bejarano; Miguel Angel Royo-Bordonada; Carlos Brotons; Luís Alvarez-Sala; Pedro Armario; Antonio Maiques; Dídac Mauricio; Susana Sans; Fernando Villar; Angel Lizcano; Antonio Gil-Núñez; Fernando de Alvaro; Pedro Conthe; Emilio Luengo; Alfonso Del Río; Olga Cortés; Ana de Santiago; Miguel A Vargas; Mercedes Martínez; Vicenta Lizarbe
Journal:  Aten Primaria       Date:  2009-07-15       Impact factor: 1.137

4.  [Improved effectiveness in the management of cardiovascular risk among type 2 diabetic patients in primary health care].

Authors:  Antonio Hormigo Pozo; María Angeles Viciana López; Leonor Gómez Jiménez; María Dolores Gallego Parrilla; Javier Orellana Lozano; José Miguel Morales Asencio
Journal:  Aten Primaria       Date:  2009-04-08       Impact factor: 1.137

5.  [New European guidelines for cardiovascular prevention and its Spanish adaptation].

Authors:  Carlos Brotons Cuixart; José Maria Lobos Bejarano
Journal:  Aten Primaria       Date:  2017-04       Impact factor: 1.137

6.  Temporal Requirement for the Protective Effect of Dietary Cholesterol against Alcohol-Induced Vasoconstriction.

Authors:  Olga Seleverstov; Kelsey North; Maria Simakova; Shivantika Bisen; Alexandra Bickenbach; Zoran Bursac; Alex M Dopico; Anna N Bukiya
Journal:  J Drug Alcohol Res       Date:  2020-10-20

7.  Implementation of Spanish adaptation of the European guidelines on cardiovascular disease prevention in primary care.

Authors:  Carlos Brotons; José Maria Lobos; Miguel Ángel Royo-Bordonada; Antonio Maiques; Ana de Santiago; Ángel Castellanos; Santiago Diaz; Juan Carlos Obaya; Juan Pedro-Botet; Irene Moral; Vicenta Lizarbe; Rosa Moreno; Antonio Pérez; Alberto Cordero; Francisco Fornés-Ubeda; Benilde Serrano-Saiz; Miguel Camafort-Babkowski; Roberto Elosua; Susana Sans; Carmen de Pablo; Antonio Gil-Nuñez; Fernando de Álvaro-Moreno; Pedro Armario; Olga Cortés Rico; Fernando Villar; Ángel Lizcano
Journal:  BMC Fam Pract       Date:  2013-03-18       Impact factor: 2.497

8.  Therapeutic implications of selecting the SCORE (European) versus the D'AGOSTINO (American) risk charts for cardiovascular risk assessment in hypertensive patients.

Authors:  Manuel A Gómez-Marcos; Carlos Martínez-Salgado; Carlos Martin-Cantera; José I Recio-Rodríguez; Yolanda Castaño-Sánchez; Maria Giné-Garriga; Emiliano Rodriguez-Sanchez; Luis García-Ortiz
Journal:  BMC Cardiovasc Disord       Date:  2009-05-11       Impact factor: 2.298

9.  Effect of cardiovascular prevention strategies on incident coronary disease hospitalisation rates in Spain; an ecological time series analysis.

Authors:  María José Medrano; Enrique Alcalde-Cabero; Cristina Ortíz; Iñaki Galán
Journal:  BMJ Open       Date:  2014-02-17       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.